The aim of the present work was to shed light on the role played by the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and memory consolidation in rodents through the inhibition of the key and rate-limiting enzyme 3-hydroxy 3-methylglutaryl Coenzyme A reductase (HMGR) both in vivo and in vitro with simvastatin. Three-month-old male Wistar rats treated for 21 days with simvastatin or vehicle were tested in the social interaction, elevated plus-maze, and inhibitory avoidance tasks; after behavioral testing, the amygdala, hippocampus, prefrontal cortex, dorsal, and ventral striatum were dissected out for biochemical assays. In order to delve deeper into the molecular mechanisms underlying the observed effects, primary rat hippocampal neurons were used. Our results show that HMGR inhibition by simvastatin induces anxiogenic-like effects in the social interaction but not in the elevated plusmaze test, and improves memory consolidation in the inhibitory avoidance task. These effects are accompanied by imbalances in the activity of specific prenylated proteins, Rab3 and RhoA, involved in neurotransmitter release, and synaptic plasticity, respectively. Taken together, the present findings indicate that the isoprenoid/cholesterol biosynthetic pathway is critically involved in the physiological modulation of both emotional and cognitive processes in rodents.

Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats / Segatto, Marco; Manduca, Antonia; Lecis, Claudio; Rosso, Pamela; Jozwiak, Adam; Swiezewska, Ewa; Moreno, Sandra; Trezza, Viviana; Pallottini, Valentina. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - 39:4(2014), pp. 841-854. [10.1038/npp.2013.284]

Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats

SEGATTO, MARCO;MANDUCA, ANTONIA;
2014

Abstract

The aim of the present work was to shed light on the role played by the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and memory consolidation in rodents through the inhibition of the key and rate-limiting enzyme 3-hydroxy 3-methylglutaryl Coenzyme A reductase (HMGR) both in vivo and in vitro with simvastatin. Three-month-old male Wistar rats treated for 21 days with simvastatin or vehicle were tested in the social interaction, elevated plus-maze, and inhibitory avoidance tasks; after behavioral testing, the amygdala, hippocampus, prefrontal cortex, dorsal, and ventral striatum were dissected out for biochemical assays. In order to delve deeper into the molecular mechanisms underlying the observed effects, primary rat hippocampal neurons were used. Our results show that HMGR inhibition by simvastatin induces anxiogenic-like effects in the social interaction but not in the elevated plusmaze test, and improves memory consolidation in the inhibitory avoidance task. These effects are accompanied by imbalances in the activity of specific prenylated proteins, Rab3 and RhoA, involved in neurotransmitter release, and synaptic plasticity, respectively. Taken together, the present findings indicate that the isoprenoid/cholesterol biosynthetic pathway is critically involved in the physiological modulation of both emotional and cognitive processes in rodents.
2014
anxiety; CREB; memory; Rab3; RhoA; simvastatin; Animals; Anticholesteremic Agents; Avoidance Learning; Brain; CREB-Binding Protein; Cells, Cultured; Cholesterol; Cognition; Emotions; Intracellular Signaling Peptides and Proteins; Male; Maze Learning; Membrane Proteins; Neurons; Rats; Rats, Wistar; Simvastatin; Synaptic Vesicles; Terpenes; Triglycerides; Pharmacology; Psychiatry and Mental Health
01 Pubblicazione su rivista::01a Articolo in rivista
Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats / Segatto, Marco; Manduca, Antonia; Lecis, Claudio; Rosso, Pamela; Jozwiak, Adam; Swiezewska, Ewa; Moreno, Sandra; Trezza, Viviana; Pallottini, Valentina. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - 39:4(2014), pp. 841-854. [10.1038/npp.2013.284]
File allegati a questo prodotto
File Dimensione Formato  
Segatto_Simvastatin_2014.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 811.59 kB
Formato Adobe PDF
811.59 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/974114
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 39
social impact